Kintara Therapeutics Announces Correction To Prior Announcement Regarding 1-for-35 Reverse Stock Split In Connection With Proposed Merger With TuHURA Biosciences, Trading To Begin Under New Symbol "HURA" On October 18, 2024
Portfolio Pulse from Benzinga Newsdesk
Kintara Therapeutics has announced a correction to its previous announcement regarding a 1-for-35 reverse stock split as part of its proposed merger with TuHURA Biosciences. The trading will begin under the new symbol 'HURA' on October 18, 2024.
October 16, 2024 | 4:56 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Kintara Therapeutics is undergoing a 1-for-35 reverse stock split as part of its merger with TuHURA Biosciences. The stock will trade under the new symbol 'HURA' starting October 18, 2024.
The reverse stock split and merger are significant corporate actions that could affect Kintara's stock price. However, the impact is neutral in the short term as the market may have already priced in the merger news. The new trading symbol 'HURA' indicates a rebranding post-merger.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100